HCM
ATRS

Harvey Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Harvey Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-534,000
Closed -$2.39M – 82
2013
Q4 		$2.39M Buy
534,000
+6,000
+1% +$24.4K 0.99% 32
2013
Q3 		$2.14M Buy
+528,000
New +$2.31M 1.09% 28

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return

Harvey Capital Management's ATRS Position: Q1 2014 in Review

Harvey Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2014, closing a stake of 534,000 shares — an estimated $2.39M sold.

Harvey Capital Management first reported a position in ATRS in Q3 2013 and held it in 2 quarters. The position peaked at $2.39M in Q4 2013. 91 funds tracked by Wall St. Rank hold ATRS as of Q1 2014.

  • Harvey Capital Management reported no remaining Antares Pharma, Inc. position as of Q1 2014 after selling out during the quarter.
  • Harvey Capital Management sold 534,000 Antares Pharma, Inc. shares in Q1 2014, an estimated $2.39M.
  • Harvey Capital Management first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 2 quarters.
  • Harvey Capital Management's Antares Pharma, Inc. position peaked at $2.39M in Q4 2013.
  • 91 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2014.

Based on Harvey Capital Management's 13F filing for Q1 2014, filed 23 Apr 2014.